Cipher Pharmaceuticals Stock Technical Analysis

CPHRFDelisted Stock  USD 2.57  0.00  0.00%   
As of the 14th of December 2024, Cipher Pharmaceuticals shows the Downside Deviation of 11.0, risk adjusted performance of 0.053, and Mean Deviation of 4.43. Cipher Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Cipher Pharmaceuticals, which can be compared to its peers. Please confirm Cipher Pharmaceuticals jensen alpha, as well as the relationship between the potential upside and skewness to decide if Cipher Pharmaceuticals is priced correctly, providing market reflects its regular price of 2.57 per share. Please also double-check Cipher Pharmaceuticals total risk alpha, which is currently at (0.93) to validate the company can sustain itself at a future point.

Cipher Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cipher, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Cipher
  
Cipher Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Cipher Pharmaceuticals technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Cipher Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cipher Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Cipher Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Cipher Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Cipher Pharmaceuticals. You can use it to identify possible trend reversals for Cipher Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cipher Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Cipher Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Cipher Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.0057  , which may suggest that Cipher Pharmaceuticals market price will keep on failing further. It has 102 observation points and a regression sum of squares at 0.73, which is the sum of squared deviations for the predicted Cipher Pharmaceuticals price change compared to its average price change.

About Cipher Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cipher Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cipher Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Cipher Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Cipher Pharmaceuticals. By analyzing Cipher Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cipher Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cipher Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.

Cipher Pharmaceuticals December 14, 2024 Technical Indicators

Most technical analysis of Cipher help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cipher from various momentum indicators to cycle indicators. When you analyze Cipher charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Cipher OTC Stock

If you are still planning to invest in Cipher Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cipher Pharmaceuticals' history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal